{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:42:57Z","timestamp":1789904577579,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jhep.2015.06.035","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T19:16:58Z","timestamp":1436987818000},"page":"1103-1110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance"],"prefix":"10.1016","volume":"63","author":[{"given":"Thomas R.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Paquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle A.","family":"Lang Kuhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Edlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Kuniholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Prokunina-Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.06.035_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2015.06.035_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2015.06.035_b0015","doi-asserted-by":"crossref","first-page":"e4933","DOI":"10.1371\/journal.pone.0004933","article-title":"The role of genomic data in the discovery, annotation and evolutionary interpretation of the interferon-lambda family","volume":"4","author":"Fox","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.06.035_b0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.06.035_b0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.06.035_b0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.06.035_b0035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-[alpha] and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.06.035_b0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.06.035_b0045","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B Is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.06.035_b0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2015.06.035_b0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAD.0000000000000052","article-title":"IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha\/ribavirin therapy failure in hepatitis C virus\/HIV-1 coinfected patients","volume":"28","author":"Franco","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2015.06.035_b0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2758","article-title":"The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs","volume":"15","author":"McFarland","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2015.06.035_b0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature09914","article-title":"Differential microRNA regulation of HLA-C expression and its association with HIV control","volume":"472","author":"Kulkarni","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.06.035_b0070","doi-asserted-by":"crossref","first-page":"e1002621","DOI":"10.1371\/journal.pcbi.1002621","article-title":"Single nucleotide polymorphisms can create alternative polyadenylation signals and affect gene expression through loss of microRNA-regulation","volume":"8","author":"Thomas","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jhep.2015.06.035_b0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","article-title":"Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1","volume":"131","author":"Conjeevaram","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.06.035_b0080","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","article-title":"Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon","volume":"359","author":"Di Bisceglie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.06.035_b0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cct.2004.08.003","article-title":"Evolution of the HALT-C trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders","volume":"25","author":"Lee","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jhep.2015.06.035_b0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-\u0394G allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2015.06.035_b0095","first-page":"75","article-title":"The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants","volume":"109","author":"Vlahov","year":"1991","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.jhep.2015.06.035_b0100","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jama.1995.03520390036028","article-title":"HIV seroprevalence in injection drug users","volume":"273","author":"Watters","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2015.06.035_b0105","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21765","article-title":"Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000","volume":"46","author":"Tseng","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.06.035_b0110","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/CDLI.12.9.1013-1019.2005","article-title":"The Women\u2019s Interagency HIV Study: an observational cohort brings clinical sciences to the bench","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jhep.2015.06.035_b0115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"Meissner","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.06.035_b0120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/597384","article-title":"Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection","volume":"199","author":"Hoofnagle","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2015.06.035_b0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2015.06.035_b0130","series-title":"The statistical evaluation of medical tests for classification and prediction","author":"Pepe","year":"2003"},{"key":"10.1016\/j.jhep.2015.06.035_b0135","doi-asserted-by":"crossref","first-page":"e31016","DOI":"10.1371\/journal.pone.0031016","article-title":"Deciphering the interleukin 28B variants that better predict response to pegylated interferon-\u03b1 and ribavirin therapy in HCV\/HIV-1 coinfected patients","volume":"7","author":"de Castellarnau","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.06.035_b0140","doi-asserted-by":"crossref","first-page":"e38578","DOI":"10.1371\/journal.pone.0038578","article-title":"Analysis of IL28B variants in an Egyptian population defines the 20kilobases minimal region involved in spontaneous clearance of hepatitis C virus","volume":"7","author":"Pedergnana","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.06.035_b0145","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/ncomms6699","article-title":"Reduced IFN\u03bb4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes","volume":"5","author":"Terczy\u0144ska-Dyla","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2015.06.035_b0150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcv.2014.01.006","article-title":"Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 \u0394G allele with higher HCV RNA decline during the first 4weeks of pegylated interferon and ribavirin therapy in HCV-1 patients","volume":"59","author":"Galmozzi","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2015.06.035_b0155","doi-asserted-by":"crossref","first-page":"e1004681","DOI":"10.1371\/journal.pgen.1004681","article-title":"Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)","volume":"10","author":"Key","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jhep.2015.06.035_b0160","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1084\/jem.20111680","article-title":"Evolutionary genetic dissection of human interferons","volume":"208","author":"Manry","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2015.06.035_b0165","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/jir.2013.0136","article-title":"IFN-\u03bb4: the paradoxical new member of the interferon lambda family","volume":"34","author":"O\u2019Brien","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jhep.2015.06.035_b0170","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/emboj.2013.232","article-title":"Interferon lambda 4 signals via the IFN\u03bb receptor to regulate antiviral activity against HCV and coronaviruses","volume":"32","author":"Hamming","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2015.06.035_b0175","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMe1401508","article-title":"Therapy for hepatitis C\u2014the costs of success","volume":"370","author":"Hoofnagle","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.06.035_b0180","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/apt.12717","article-title":"Review article: genetic factors that modify the outcome of viral hepatitis","volume":"39","author":"St\u00e4ttermayer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.06.035_b0185","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/infdis\/jit827","article-title":"IFNL4-\u0394G genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin","volume":"209","author":"Meissner","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2015.06.035_b0190","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa1213557","article-title":"Faldaprevir and deleobuvir for HCV genotype 1 infection","volume":"369","author":"Zeuzem","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.06.035_b0195","article-title":"Subgroup differences in response to 8weeks of ledipasvir\/sofosbuvir for chronic hepatitis C","volume":"1","author":"O\u2019Brien","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhep.2015.06.035_b0200","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.06.035_b0205","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv057","article-title":"Reply: subgroup differences in response to 8weeks of ledipasvir\/sofosbuvir for chronic hepatitis C","volume":"2","author":"O\u2019Brien","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhep.2015.06.035_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","author":"AASLD IDSA HCV Guidance Panel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.06.035_b0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815004651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815004651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T22:29:37Z","timestamp":1599258577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815004651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0168827815004651"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.06.035","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}